AI speeds up drug discovery for Alzheimer's Parkinson's and MND
Technology
Artificial intelligence (AI) is speeding up the search for treatments for brain disorders like Alzheimer's disease, Parkinson's disease, and motor neuron disease (MND).
By crunching huge amounts of data (think patient records, brain scans, and genetics), AI spots promising drug candidates much faster than old-school methods.
This shift helps tackle the usual slow pace and high costs that have held back progress in this field.
AI uncovers drug repurposing opportunities
A big win for AI is drug repurposing: finding new uses for existing medicines by connecting dots between diseases, symptoms, and molecules.
It also gives researchers deeper insight into how these disorders develop, helping them create targeted therapies and catch problems earlier.